The neuronal ceroid lipofuscinoses (NCLs) represent a group of common recessive inherited neurodegenerative disorders of childhood, with an incidence of 1:12,500 live births1. They are characterized by accumulation of autofluorescent lipopigments in various tissues. Several forms of NCLs have been identified, based on age at onset, progression of disease, neurophysiological and histopathological findings and separate genetic loci2,3,4,5,6,7,8,9. All types of NCL cause progressive visual and mental decline, motor disturbance, epilepsy and behavioral changes, and lead to premature death. One of the subtypes, Finnish variant late infantile neuronal ceroid lipofuscinosis (vLINCL; MIM256731) affects children at 4–7 years of age10,11. The first symptom is motor clumsiness, followed by progressive visual failure, mental and motor deterioration and later by myoclonia and seizures. We have previously reported linkage for vLINCL on chromosome 13 (ref. 5) and constructed a long-range physical map over the region12. Here, we report the positional cloning of a novel gene, CLN5, underlying this severe neurological disorder. The gene encodes a putative transmembrane protein which shows no homology to previously reported proteins. Sequence analysis of DNA samples from patients with three different haplotypes revealed three mutations; one deletion, one nonsense and one missense mutation, suggesting that mutations in this gene are responsible for vLINCL.
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Rider, J.A. & Rider, D.L. Batten disease: Past, present and future. Am. J. Med. Genet. (Suppl.) 5, 21 –26 (1988).
Santavuori, P. Neuronal ceroid lipofuscinosis in childhood. Brain Dev. 10, 80–83 (1988).
Gardiner, R.M. et al. Batten disease (Spielmeyer-Vogt; juvenile onset neuronal ceroid lipofuscinosis) maps to human chromosome 16. Genomics 8, 387–390 (1990).
Järvelä, I. et al. Infantile neuronal ceroid lipofuscinosis (INCL, CLN1) maps to the short arm of chromosome 1. Genomics 8, 170 –173 (1991).
Savukoski, M. et al. Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am. J. Hum. Genet. 55, 695–701 (1994).
Sharp, J. et al. Loci for classical and variant late infantile neuronal caroid lipofuscinosis map to chromosomes 11p15 and 15q21-23. Hum. Mol. Genet. 6, 591–595.
Vesa, J. et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376, 584– 587 (1995).
The International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell 82, 949–957 ( 1995).
Sleat, D.E. et al. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277, 1802–1805 (1997).
Santavuori, P., Rapola, J., Sainio, K. & Raitta, C. A variant of Jansky-Bieschowsky disease. Neuropaediatrics 13, 135– 141 (1982).
Santavuori, P. et al. Early juvenile neuronal ceroid lipofuscinosis or variant Jansky-Bielschowsky disease: diagnostic criteria and nomenclature. J. Inher. Metab. Dis. 16, 230–232 ( 1993).
Klockars, T. et al. Efficient construction of a physical map by fiber-fish of the CLN5 region: refined assignment and long-range contig covering the critical region on 13q22 . Genomics 35, 71–78 (1996).
Reese, M.G., Harris, N.L. & Eeckman, F.H. Large scale sequencing specific neural networks for promoter and splice site recognition. in Proceedings of the Pacific Symposium on Biocomputing. (eds Hunter, L. & Klein, T., Kona, 1996).
Varilo, T. et al. The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population. Am. J. Hum. Genet. 58, 506–512 ( 1996).
Nakai, K. & Kanehisa, M. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics 14, 897–911 (1992).
Solovyev, V.V. & Salamov, A.A. Predicting α-helix and ß-strand segments of globular proteins. Comput. Appl. Biosci. 10, 661–669 (1994).
Hofmann, K. & Stoffel, W. TMBASE- A database of membrane spanning protein segments. Biol. Chem. Hoppe-Seyler 374, 166 (1993).
Hellsten, E., Vesa, J., Olkkonen, V., Jalanko, A. & Peltonen, L. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO J. 15, 5240– 5245 (1996).
Järvelä, I. et al. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum. Mol. Genet. 7, 85 –70 (1998).
Maniatis, T., Fritsch, E.S. & Sambrook, J. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1982 ).
Syvänen, A.C., Aalto-Setälä, K., Kontula, K. & Söderlund, H. Direct sequencing of affinity captured amplified human DNA: application to the detection of apolipoprotein E polymorphisms. FEBS Lett. 258, 71–74 (1989).
Syvä nen, A.C., Sajantila, A. & Lukka, M. Identification of individuals by analysis of biallelic DNA markers, using PCR and Solid-Phase minisequencing. Am. J. Hum. Genet. 52, 46–59 ( 1993).
Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. Basic local alignment search tool. J. Mol. Biol. 215, 403–419 ( 1990).
Kyte, J. & Doolittle, R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105–132 (1982).
About this article
Cite this article
Savukoski, M., Klockars, T., Holmberg, V. et al. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet 19, 286–288 (1998). https://doi.org/10.1038/975
Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force
Movement Disorders (2019)
Molecular Neurodegeneration (2019)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019)
Molecular Genetics & Genomic Medicine (2019)